Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells

Human Molecular Genetics

Volumn 22, Issue 13, 2013, Pages 2705-2722

  Sahoo, Swagatika ^a   Thiele, Ines ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 5 METHYLTETRAHYDROFOLIC ACID; AMINO ACID TRANSPORTER; CARBON DIOXIDE; CITRULLINE; DIHYDROFOLATE REDUCTASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 2; GLUTAMINE; GLYCEROL KINASE; PROLINE; TRIACYLGLYCEROL;

ABSORPTION; ACUTE INTERMITTENT PORPHYRIA; ARTICLE; BIOMASS; CALCIFYING CHONDRODYSTROPHY; CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY; CARBOHYDRATE METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CELLULAR SECRETION; CHOLESTEROL INTAKE; CHOLESTEROL SYNTHESIS; CITRULLINEMIA; COPROPORPHYRIA; CYSTINURIA; DIABETES MELLITUS; DIET; DIETARY FIBER; DIETARY REFERENCE INTAKE; ENERGY YIELD; EPITHELIUM CELL; FATTY ACID OXIDATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLUCONEOGENESIS; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN STORAGE DISEASE; HEME SYNTHESIS; HEREDITARY FRUCTOSE INTOLERANCE; HISTIDINEMIA; HUMAN; HUMAN CELL; HYPERARGININEMIA; INBORN ERROR OF METABOLISM; INTESTINE CELL; INTESTINE EPITHELIUM CELL; LACTASE DEFICIENCY; LIPID METABOLISM; LYSINURIC PROTEIN INTOLERANCE; METHYLMALONIC ACIDEMIA; METHYLMALONIC ACIDURIA; MEVALONIC ACIDURIA; NUCLEOTIDE METABOLISM; OBESITY; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PORPHYRIA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; RETINA GYRATE ATROPHY; SMALL INTESTINE; SMITH LEMLI OPITZ SYNDROME;

DIET; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS;

EID: 84878949529     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt119     Document Type: Article

References (119)

1. Gropper, S.A.S., Smith, J.L. and Groff, J.L. (2009) Advanced nutrition and human metabolism. Wadsworth/Cengage Learning, Australia; United States.
2. Goodman, B.E. (2010) Insights into digestion and absorption of major nutrients in humans. Adv. Physiol. Educ., 34, 44-53.
3. Mithieux, G. (2001) New data and concepts on glutamine and glucose metabolism in the gut. Curr. Opin. Clin. Nutr. Metab. Care., 4, 267-271.
4. Dietschy, J.M. and Siperstein, M.D. (1965) Cholesterol synthesis by the gastrointestinal tract: localization and mechanisms of control. J. Clin. Invest., 44, 1311-1327.
5. Lin, J.H., Chiba, M. and Baillie, T.A. (1999) Is the role of the small intestine in first-pass metabolism overemphasized?. Pharmacol. Rev., 51, 135-158.
6. Pang, K.S. (2003) Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series). Drug Metab. Dispos., 31, 1507-1519.
7. Guyton, A.C. and Hall, J.E. (2000) Text book of medical physiology. W.B. Saunders company.
8. Fernandes, J. (2006) Inborn metabolic diseases: diagnosis and treatment. Springer, Heidelberg.
9. Mootha, V.K. and Hirschhorn, J.N. (2010) Inborn variation in metabolism. Nat. Genet., 42, 97-98.
10. Roy, C.N. and Andrews, N.C. (2001) Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum. Mol. Genet., 10, 2181-2186.
11. Martins, A.M. (1999) Inborn errors of metabolism: a clinical overview. Sao Paulo Med. J., 117, 251-265.
12. Palsson, B. (2006) Systems biology: properties of reconstructed networks. Cambridge University Press, Cambridge.
13. Duarte, N.C., Becker, S.A., Jamshidi, N., Thiele, I., Mo, M.L., Vo, T.D., Srivas, R. and Palsson, B.O. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl Acad. Sci. USA, 104, 1777-1782.
14. Sigurdsson, M.I., Jamshidi, N., Steingrimsson, E., Thiele, I. and Palsson, B.O. (2010) A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst. Biol., 4, 140.
15. Gille, C., Bolling, C., Hoppe, A., Bulik, S., Hoffmann, S., Hubner, K., Karlstadt, A., Ganeshan, R., Konig, M., Rother, K. et al. (2010) HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol., 6, 411.
16. Chang, R.L., Xie, L., Bourne, P.E. and Palsson, B.O. (2010) Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol, 6, e1000938.
17. Bordbar, A., Lewis, N.E., Schellenberger, J., Palsson, B.O. and Jamshidi, N. (2010) Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol., 6, 422.
18. Bordbar, A., Jamshidi, N. and Palsson, B.O. (2011) iAB-RBC-283: a proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states. BMC Syst. Biol., 5, 110.
19. Zhao, Y. and Huang, J. (2011) Reconstruction and analysis of human heart-specific metabolic network based on transcriptome and proteome data. Biochem. Biophys. Res. Commun., 415, 450-454.
20. Sahoo, S., Franzson, L., Jonsson, J.J. and Thiele, I. (2012) A compendium of inborn errors of metabolism mapped onto the human metabolic network. Mol. Biosyst., 8, 2545-2558.
21. Heinken, A., Sahoo, S., Fleming, R.M. and Thiele, I. (2012) Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes, 4, 28-40.
22. Shlomi, T., Cabili, M.N. and Ruppin, E. (2009) Predicting metabolic biomarkers of human inborn errors of metabolism. Mol. Syst. Biol., 5, 263.
23. Jamshidi, N., Vo, T.D. and Palsson, B.O. (2007) In silico analysis of SNPs and other high-throughput data. Methods Mol. Biol., 366, 267- 285.
24. Lee, D.S., Park, J., Kay, K.A., Christakis, N.A., Oltvai, Z.N. and Barabasi, A.L. (2008) The implications of human metabolic network topology for disease comorbidity. Proc. Natl Acad. Sci. USA, 105, 9880-9885.
25. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E. and Shlomi, T. (2011) Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol., 7, 517.
26. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K.N., MacKenzie, E.D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A. et al. (2011) Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature, 477, 225-228.
27. Thiele, I., Price, N.D., Vo, T.D. and Palsson, B.O. (2005) Candidate metabolic network states in human mitochondria: Impact of diabetes, ischemia, and diet. J. Biol. Chem., 280, 11683-11695.
28. Sigurdsson, M.I., Jamshidi, N., Jonsson, J.J. and Palsson, B.O. (2009) Genome-scale network analysis of imprinted human metabolic genes. Epigenetics, 4, 43-46.
29. Le Gall, M., Tobin, V., Stolarczyk, E., Dalet, V., Leturque, A. and Brot-Laroche, E. (2007) Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism. J. Cell. Physiol., 213, 834-843.
30. Orth, J.D., Thiele, I. and Palsson, B.O. (2010) What is flux balance analysis? Nat. Biotechnol., 28, 245-248.
31. Mahadevan, R. and Schilling, C.H. (2003) The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng., 5, 264-276.
32. U.S. Department of Agriculture, A.R.S. (NHANES 2007-2008).
33. U.S.Department ofAgriculture,A.R.S.U.N.N.D.f.S.R.,Release 24.Nutrient Data Laboratory Home Page. http://www.ars.usda.gov/nutrientdata.
34. (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). The National Academies Press, Washington, DC.
35. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S., Goldstein, J.L. and Brown, M.S. (1983) The Metabolic Basis of Inherited Disease. McGraw-Hill Book Company, New York, NY.
36. Treacy, E., Arbour, L., Chessex, P., Graham, G., Kasprzak, L., Casey, K., Bell, L., Mamer, O. and Scriver, C.R. (1996) Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate. J. Pediatr., 129, 445-448.
37. Thoene, J.G. (1993) Citrullinemia Type I. In Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K., Adam, M.P. (eds), GeneReviewsTM [Internet], University of Washington, Seattle; 1993-2004 Jul 07 [updated 2011 Aug 11].
38. Irons, M. (1993) Smith-Lemli-Opitz syndrome. In Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K., Adam, M.P. (eds), GeneReviewsTM [Internet], University of Washington, Seattle; 1993-1998 Nov 13 [updated 2007 Oct 24].
39. Broer, S. (2008) Apical transporters for neutral amino acids: physiology and pathophysiology. Physiology (Bethesda), 23, 95-103.
40. Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., Smith, S.C. Jr. and Lenfant, C. (2004) Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433-438.
41. Zivkovic, A.M., German, J.B. and Sanyal, A.J. (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am. J. Clin. Nutr., 86, 285-300.
42. Jalal, D.I., Smits, G., Johnson, R.J. and Chonchol, M. (2010) Increased fructose associates with elevated blood pressure. J. Am. Soc. Nephrol., 21, 1543-1549.
43. Kawasaki, T., Akanuma, H. and Yamanouchi, T. (2002) Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care, 25, 353-357.
44. Ainscough, R., Bardill, S., Barlow, K., Basham, V., Baynes, C., Beard, L., Beasley, A., Berks, M., Bonfield, J., Brown, J. et al. (1998) Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans Sequencing Consortium. Science, 282, 2012- 2018.
45. Lehninger, A.L., Nelson, D.L. and Cox, M.M. (2000) Principles of biochemistry. Worth Publishers, New York.
46. Flock, M.R. and Kris-Etherton, P.M. (2011) Dietary Guidelines for Americans 2010: implications for cardiovascular disease. Curr. Atheroscler. Rep., 13, 499-507.
47. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C. Jr. et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation, 112, 2735-2752.
48. Thunell, S. (2000) Porphyrins, porphyrin metabolism and porphyrias. I. update. Scand. J. Clin. Lab. Invest., 60, 509-540.
49. Budhoo, M.R., Mitchell, S., Eddlestone, J. and MacLennan, I. (1999) Sickle cell trait and acute intermittent porphyria leading to small bowel infarction. J. R. Coll. Surg. Edinb., 44, 130-131.
50. Twaddle, S., Wassif, W.S., Deacon, A.C. and Peters, T.J. (2001) Case report: celiac disease in patients with Variegate porphyria. Dig. Dis. Sci., 46, 1506-1508.
51. Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N. and Ames, B.N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science, 235, 1043-1046.
52. Oates, P.S. and West, A.R. (2006) Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility. World J. Gastroenterol., 12, 4281-4295.
53. Gibbons, S.J. and Farrugia, G. (2004) The role of carbon monoxide in the gastrointestinal tract. J. Physiol., 556, 325-336.
54. Zuckerbraun, B.S., Otterbein, L.E., Boyle, P., Jaffe, R., Upperman, J., Zamora, R. and Ford, H.R. (2005) Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol., 289, G607-G613.
55. Sieg, I., Beckh, K., Kersten, U. and Doss, M.O. (1991) Manifestation of acute intermittent porphyria in patients with chronic inflammatory bowel disease. Z. Gastroenterol., 29, 602-605.
56. Camacho, J. and Rioseco-Camacho, N. (1993) Hyperornithinemia- hyperammonemia-homocitrullinuria Syndrome.
57. Valtonen, M., Nanto-Salonen, K., Jaaskelainen, S., Heinanen, K., Alanen, A., Heinonen, O.J., Lundbom, N., Erkintalo, M. and Simell, O. (1999) Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J. Inherit. Metab. Dis., 22, 855-866.
58. Lanpher, B.C., Gropman, A., Chapman, K.A., Lichter-Konecki, U., Urea Cycle Disorders, C. and Summar, M.L. (1993) Urea cycle disorders overview. In Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K., Adam, M.P. (eds), GeneReviewsTM [Internet], University of Washington, Seattle; 1993-2003 Apr 29 [updated 2011 Sep 01].
59. Wang, F.Y., Zhu, R.M., Maemura, K., Hirata, I., Katsu, K. and Watanabe, M. (2006) Expression of gamma-aminobutyric acid and glutamic acid decarboxylases in rat descending colon and their relation to epithelial differentiation. Chin. J. Dig. Dis., 7, 103-108.
60. Collins, S.M. and Bercik, P. (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology, 136, 2003-2014.
61. Prins, A. (2011) The brain-gut interaction: the conversation and the implications. S. Afr. J. Clin. Nutr, 24, s8-s14.
62. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J. and Cryan, J.F. (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl Acad. Sci. USA, 108, 16050-16055.
63. Mani, S., Yang, G. and Wang, R. (2011) A critical life-supporting role for cystathionine g-lyase in the absence of dietary cysteine supply. Free Radic. Biol. Med., 50, 1280-1287.
64. Heil, S.G., Hogeveen, M., Kluijtmans, L.A., van Dijken, P.J., van de Berg, G.B., Blom, H.J. and Morava, E. (2007) Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type). J. Inherit. Metab. Dis., 30, 811.
65. Leonard, J.V. (1995) The management and outcome of propionic and methylmalonic acidaemia. J. Inherit. Metab. Dis., 18, 430-434.
66. Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M. and Braun, A. (2010) Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig. Dis., 28, 490-496.
67. Schneider, H., Braun, A., Fullekrug, J., Stremmel, W. and Ehehalt, R. (2010) Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int. J. Mol. Sci., 11, 4149-4164.
68. Fenton, W.A., Gravel, R.A. and Rosenblatt, D.S. (2001), In The metabolic and molecular bases of inherited disease. McGraw-Hill Companies, New York, Vol. 2, pp. 2165-2193.
69. Gudmundsson, S. and Thiele, I. (2010) Computationally efficient flux variability analysis. BMC Bioinformatics, 11, 489.
70. Schellenberger, J., Park, J.O., Conrad, T.M. and Palsson, B.O. (2010) BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics, 11, 213.
71. Maglott, D., Ostell, J., Pruitt, K.D. and Tatusova, T. (2011) Entrez gene: gene-centered information at NCBI. Nucleic Acids Res., 39, D52-D57.
72. Consortium, T.U. (2012) Reorganizing the protein space at the universal protein resource (UniProt). Nucleic Acids Res., 40, D71-D75.
73. Scheer, M., Grote, A., Chang, A., Schomburg, I., Munaretto, C., Rother, M., Sohngen, C., Stelzer, M., Thiele, J. and Schomburg, D. (2011) BRENDA, the enzyme information system in 2011. Nucleic Acids Res., 39, D670-D676.
74. Thorleifsson, S.G. and Thiele, I. (2011) rBioNet: a COBRA toolbox extension for reconstructing high-quality biochemical networks. Bioinformatics, 27, 2009-2010.
75. Thiele, I. and Palsson, B.O. (2010) A protocol for generating a high-quality genome-scale metabolic reconstruction. Nature Protocols, 5, 93-121.
76. Murray, R.K., Bender, D.A., Botham, K.M., Kennelly, P.J., Rodwell, V.W. and Weil, P.A. (2009) Harper's Illustrated Biochemistry. McGraw Hill Medical, New York, NY.
77. Lockhart, R.D., Hamilton, G.F. and Fyfe, F.W. (1974) Anatomy of the human body. R. MacLehose & company limited, London.
78. Wise, E.M. Jr. and Elwyn, D. (1965) Rates of reactions involved in phosphatide synthesis in liver and small intestine of intact rats. J. Biol. Chem., 240, 1537-1548.
79. McDevitt, J., Feighery, C., O'Farrelly, C., Martin, G., Weir, D.G. and Kelleher, D. (1995) Effects of tumour necrosis factor-alpha on BrdU incorporation in cultured human enterocytes. Mediators Inflamm., 4, 31- 37.
80. Bouchoux, J., Beilstein, F., Pauquai, T., Guerrera, I.C., Chateau, D., Ly, N., Alqub, M., Klein, C., Chambaz, J., Rousset, M. et al. (2011) The proteome of cytosolic lipid droplets isolated from differentiated Caco-2/TC7 enterocytes reveals cell-specific characteristics. Biol. Cell, 103, 499-517.
81. Schellenberger, J., Que, R., Fleming, R.M., Thiele, I., Orth, J.D., Feist, A.M., Zielinski, D.C., Bordbar, A., Lewis, N.E., Rahmanian, S. et al. (2011) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc., 6, 1290-1307.
82. Fernandez, M.L. and Calle, M. (2010) Revisiting dietary cholesterol recommendations: does the evidence support a limit of 300 mg/d? Curr. Atheroscler. Rep., 12, 377-383.
83. Chougule, P., Herlenius, G., Hernandez, N.M., Patil, P.B., Xu, B. and Sumitran-Holgersson, S. (2012) Isolation and characterization of human primary enterocytes from small intestine using a novel method. Scand. J. Gastroenterol., 47, 1334-1343.
84. Paine, M.F., Khalighi, M., Fisher, J.M., Shen, D.D., Kunze, K.L., Marsh, C.L., Perkins, J.D. and Thummel, K.E. (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther., 283, 1552-1562.
85. Crenn, P., Messing, B. and Cynober, L. (2008) Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clinical Nutr., 27, 328-339.
86. Kohler, E.S., Sankaranarayanan, S., van Ginneken, C.J., van Dijk, P., Vermeulen, J.L., Ruijter, J.M., Lamers, W.H. and Bruder, E. (2008) The human neonatal small intestine has the potential for arginine synthesis; developmental changes in the expression of arginine-synthesizing and -catabolizing enzymes. BMC Dev. Biol., 8, 107.
87. Yamada, E., Wakabayashi, Y., Saito, A., Yoda, K., Tanaka, Y. and Miyazaki, M. (1993) Hyperammonaemia caused by essential aminoacid supplements in patient with short bowel. Lancet, 341, 1542-1543.
88. Lecha, M., Puy, H. and Deybach, J.C. (2009) Erythropoietic protoporphyria. Orphanet J. Rare Dis., 4, 19.
89. Barnes, H.D., Hurworth, E. and Millar, J.H. (1968) Erythropoietic porphyrin hepatitis. J. Clin. Pathol., 21, 157-159.
90. Meerman, L., Koopen, N.R., Bloks, V., van Goor, H., Havinga, R., Wolthers, B.G., Kramer, W., Stengelin, S., Müller, M., Kuipers, F. et al. (1999) Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology, 117, 696-705.
91. Donovan, A., Roy, C.N. and Andrews, N.C. (2006) The ins and outs of iron homeostasis. Physiology, 21, 115-123.
92. Vassallo, M.J., Camilleri, M., Sullivan, S.N. and Thomforde, G.M. (1992) Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J. Clin. Gastroenterol., 14, 255-259.
93. Migchielsen, A.A., Breuer, M.L., van Roon, M.A., te Riele, H., Zurcher, C., Ossendorp, F., Toutain, S., Hershfield, M.S., Berns, A. and Valerio, D. (1995) Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat. Genet., 10, 279-287.
94. Pita, A.M., Fernandez-Bustos, A., Rodes, M., Arranz, J.A., Fisac, C., Virgili, N., Soler, J. and Wakabayashi, Y. (2004) Orotic aciduria and plasma urea cycle-related amino acid alterations in short bowel syndrome, evoked by an arginine-free diet. JPEN J. Parenter. Enteral. Nutr., 28, 315-323.
95. Hendriksz, C.J. and Gissen, P. (2011) Glycogen storage disease. Paediatr. Child Health, 21, 84-89.
96. Guery, M.J., Douillard, C., Marcelli-Tourvieille, S., Dobbelaere, D., Wemeau, J.L. and Vantyghem, M.C. (2007) Doctor, my son is so tired. . . about a case of hereditary fructose intolerance. Ann. Endocrinol., 68, 456-459.
97. Buchman, A.L. (2006) Clinical nutrition in gastrointestinal disease. SLACK incorporated, USA.
98. Chung-Faye, G., Hayee, B., Maestranzi, S., Donaldson, N., Forgacs, I. and Sherwood, R. (2007) Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation. Inflamm. Bowel Dis., 13, 1374-1378.
99. Savilahti, E., Launiala, K. and Kuitunen, P. (1983) Congenital lactase deficiency.A clinical study on 16 patients. Arch. Dis. Child., 58, 246-252.
100. Walker, W.A. (2004) Pediatric gastrointestinal disease: pathophysiology, diagnosis, management.
101. Visser, D. and Heijnen, J.J. (2002) The mathematics of metabolic control analysis revisited. Metab. Eng., 4, 114-123.
102. Milla, P.J., Atherton, D.A., Leonard, J.V., Wolff, O.H. and Lake, B.D. (1978) Disordered intestinal function in glycogen storage disease. J. Inherit. Metab. Dis., 1, 155-157.
103. Bali, D.S., Chen, Y.T. and Goldstein, J.L. (1993) Glycogen storage disease Type I. In Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K., Adam, M.P. (eds), GeneReviewsTM [Internet], University of Washington, Seattle; 1993-2006 Apr 19 [updated 2010 Dec 23].
104. Pascual, J.M., Wang, D., Lecumberri, B., Yang, H., Mao, X., Yang, R. and De Vivo, D.C. (2004) GLUT1 deficiency and other glucose transporter diseases. Eur. J. Endocrinol., 150, 627-633.
105. Golachowska, M.R., van Dael, C.M., Keuning, H., Karrenbeld, A., Hoekstra, D., Gijsbers, C.F., Benninga, M.A., Rings, E.H. and van Ijzendoorn, S.C. (2012) MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome. J. Pediatr. Gastroenterol. Nutr., 54, 491-498.
106. Jacob, R., Zimmer, K.P., Schmitz, J. and Naim, H.Y. (2000) Congenital sucrose-isomaltase deficiency arising from cleavage and secretion of a mutant form of the enzyme. J. Clin. Invest., 106, 281-287.
107. Iyer, R.K., Yoo, P.K., Kern, R.M., Rozengurt, N., Tsoa, R., O'Brien, W.E., Yu, H., Grody, W.W. and Cederbaum, S.D. (2002) Mouse model for human arginase deficiency. Mol. Cell. Biol., 22, 4491-4498.
108. Claes, D.J. and Jackson, E. (2012) Cystinuria: mechanisms and management. Pediatr. Nephrol.
109. Wadman, S.K., Sprang, F.J.V., Stekelenburg, G.J.V. and de Bree, P.K. (1967) Three new cases of histidinemia. Acta Paediatr., 56, 485-492.
110. Cathelineau, L., Briand, P., Rabier, D. and Navarro, J. (1985) Ornithine transcarbamylase and disaccharidase activities in damaged intestinal mucosa of children-diagnosis of hereditary ornithine transcarbamylase deficiency in mucosa. J. Pediatr. Gastroenterol. Nutr., 4, 960-964.
111. Janne, J., Alhonen, L., Keinanen, T.A., Pietila, M., Uimari, A., Pirinen, E., Hyvonen, M.T. and Jarvinen, A. (2005) Animal disease models generated by genetic engineering of polyamine metabolism. J. Cell Mol. Med., 9, 865-882.
112. Reinoso, M.A., Whitley, C., Jessurun, J. and Schwarzenberg, S.J. (1998) Lysinuric protein intolerance masquerading as celiac disease: a case report. J. Pediatr., 132, 153-155.
113. Fairbanks, T. and Emil, S. (2005) Colonic perforation in the first few hours of life associated with rhizomelic chondrodysplasia punctata. Pediatr. Surg. Int., 21, 662-664.
114. Nimubona, L., Laloum, D., Rolland, M.O., Read, M.H., Guillois, B. and Duhamel, J.F. (2002) An intestinal obstruction in an eight-month-old child suffering from mevalonic aciduria. Acta Paediatr., 91, 714-716.
115. Hoflack, M., Caruba, C., Pitelet, G., Haas, H., Mas, J.C., Paquis, V. and Berard, E. (2010) Infant coma in the emergency department: 2 cases of MCAD deficiency. Arch. Pediatr., 17, 1074-1077.
116. Gilbert, J. and Ibdah, J.A. (2005) Intestinal pseudo-obstruction as a manifestation of impaired mitochondrial fatty acid oxidation. Med. Hypotheses, 64, 586-589.
117. Lee, M., Cook, C.R. and Wilkins, I. (2007) A new association of second-trimester echogenic bowel and metabolic disease of the neonate. J. Ultrasound Med., 26, 1119-1122.
118. Shinton, N.K. (1972) Vitamin B 12 and folate metabolism. Br. Med. J., 1, 556-559.
119. Klein, R.D., Thorland, E.C., Gonzales, P.R., Beck, P.A., Dykas, D.J., McGrath, J.M. and Bale, A.E. (2006) A multiplex assay for the detection and mapping of complex glycerol kinase deficiency. Clin. Chem., 52, 1864-1870.